INTRODUCTION
H emoPhagOCyticsyndrome has been described as a disorder of morphologically normal macrophages.
The clinicaI features are fever, hepatosplenomegaly, lymphoadenopathy and pancytopenia, secondary to a phenomenon of phagocytosis of hematological elements and their precursors in bone marrow and peripherallymphoid organs 1 ,2,3. This syndrome has been associated to viral infections, especiall y the EpsteinBarr virus, cytomegalovirus and adenovirus. In this context it has been called "virus-associated hemophagocytic syndrome" (VAHS). There are reports associating HS with infections caused by bacteria, mycobacteria, fungi and parasites as wel1 as carcin9mas and lymphomas, mainly ofT cel1s 1 ,2,4,5. HS may occur in young children as an isolated disease named hemophagocytic lymphohistiocytosis 2 ,6. HS may also be associated with other diseases, such as systemic lupus erythematosus, Weber-Christian disease, sarcoidosis and drug-induced agranulocytosis1,2,3.
Although phagocytosis of hemopoietic precursors by macrophages in bone marrow is not uncommon, HS is considered rare 2 • Its incidence may be higher in a referral hospital and its diagnosis requires attention The anatomo-pathological evaluation of the many organs involved shows the phenomenon of hemophagocytosisby morphologicallynormal macrophages, in .bone marrow, liver, spleen and lymph nodes. It may also be found in the meninges or the skin 2 ,3. The pathophysiology is quite unclear, but probably a variety of cytokines are involved. Some specific events may start an uncontrolled activation of the cellular immune system. Through .the release of IFN gamma and IL-2, cytotoxic T-Iymphocytes and CD8 + lymphocytes activate the macrophage cytokines, especially TNF, PGF2 alpha, PGE2 and IL6. These cytokines show specific and interactive functions and lead to clinicaI manifestations of fever, coagulopathy, lipidic changes, phagocytosis, anemia, leukopenia and thrombocytopenia. Macrophagic activation .also leads to hyperferritinemia and alterations of lipidic enzymes.
CASE REPORT E.A.G.S., a 19-year-old white male, presented a history of two months with ecchymosis and gingivorrhagia. No other signs and symptoms were found. He had been treated for idiopathic thrombocytopenic purpura (ITP) six years earlier. Physical examination showed a young man in a good general condition, except for petechiae and ecchymosis. Hemoglobin: 14,3°g/dl; MCV 83 fi; MCH 26 pg; leukocytes: 5,1x10
9 /1, with 62% polymorphonuclear neutrophils, 4% eosinophils, 2% basophils, 27% lymphocytes and 5% monocytes; platelets: 5x10 9 /1. Screening coagulation tests were normal. Bone marrow cytology showed unspecific alterations. Prednisone 1mg/ kg was introduced, considering a diagnostic hypothesis of ITP.
One week later, the patient presented fever a~d cellulitis in the right limbo .Blood counts remained unchanged. The patient was hospitalized and treated with antibiotics. Laboratory tests for renal and hepatic functions were normal. The serology for HIV 1 and HIV 2, hepatitis B, hepatitis C virus, cytomegalovirus and Epstein-Barr virus, as well as syphilis and toxoplasmosis, were negative. LE cells, Anti-Ro(SSA), Anti-Sm, Anti-Ia(SSb), Anti-RNP, Anti-DNA and antiphospholipid antibodies were negative. Chest X-ray and transthoracic echocardiogram were normal. A slightly enlarged liver and spleen were found by abdominal'ultra-sound.
Bone marrow cytology and histology showed increased cellularity, dyserythropoiesis and a slight decrease in granulocytic precursors, a slight increase in the megacaryocytic series and frequent macrophages showing hemophagocytosis. Immunohistochemical stain for UCHL-1, L26 and lysozyme were performed in order to exclude bone marrow involvement by lymphoma. Immunostain by lysozyme showed clearly the large number of macrophages with hemophagocytosis ( fig.1) . Cytogenetic analysis showed a 46XY karyotype.
Ten days later, hemoglobin was 11,0 g/dl, hematocrit 34%, leukocytes 1,lx10
9 /1 (35% segmented neutrophils, 60% lymphocytes and 5% monocytes) and platelets 2x10 9 /
1.
Blood biochemistry remained normal. Hepatosplenomegaly had increased. Bone marrow biopsy was repeated but findings remained unchanged. A new investigation for viruses, bacteria, mycobacteria and fungi was performed but no agent was isolated. After 15 days, the chest X-ray showed a diffuse interstitial infiltrate. The patient presented abdominal distention and abdominal ultra-sonography and tomography showed a moderate enlargement of spleenand liver. Then, the patient progressed to coma, and presented clinicaI and laboratory features of consumption coagulopathy. CT of the skull was normal. Cerebrospinal fluid evaluation showed proteinorrhachia of 81 mg/dl, with no other changes. The electroencephalogram was compatible with diffuse encephalopathy. Despite receiving intensive care, the patient died in a few days. An autopsy was performed. The main necroscopical findings were: intensely hypercellular bone marrow with moderate increase in erythroblasts, increase in more immature granulopoietic precursors and intense' histiocytosis with hemophagocytosis ( fig. 1) ; the liver showed slight, focal portal lymphohistiocytic infiltration, and hyperplasia of Kupffer cells with moderate hemophagocytosis (fig. 2) ; lymph nodes showed normal architecture but had an Diffuse alveolar injury (initial phase) and hemorrhagic bronchopneumonia were found in the lungs. The brain presented focal subarachnoid hemorrhage and meningeallymphohistiocytic infiltration.
DISCUSSION
Hemophagocytosis is defined as a condition in which the phagocytosis of hemopoietic precursor cells by macrophages of normal appearance is observed in bone marrow, lymph nodes, spleen or liver. This phenomenon may occur in a variety of clinicaI states, including familial hemophagocytic lymphohistiocytosis, viral infections and malignant histiocytosis, as well as some types of malignant lymphomas1.2.3.5 . Virus-associated hemophagocytic syndrome (V.A.H.S.) was first described in immunodeficient patients 7 , in whom previously described findings were associated to viral infections. More recently it has been observed in immunocompetent patients. The main viruses involved are Epstein-Barr virus, cytomegalovirus, adenovirus and parvovirus B 19. The clinicaI course is often fatal, despite specific treatment for infection and for hemophagocytic syndrome with immunosuppressive drugs. The hemophagocytic syndrome, described in HIV positive patients, is generally associated with other viruses, especially the Epstein~Barr virus, or to other infections 2,3,7,10.
Secondary hemophagocytic syndrome occurs in infections by Gram-negative bacteria, tuberculosis, kalaazar and fungi 11,14. It was also observed in patients with Tcelllymphomas, in some cases with the presence of the Epstein-Barr virus 11 ,12,13. Hemophagocytic syndrome has been described in other diseases: in Weber-Christian's disease (as a histiocytic cytophagic panniculitis) 7 ;in the advanced phase of ChediakHigashi's syndrome 1 ; in systemic lupus erythematosus 7 and in patients receiving parenteral feeding with a high lipid content 2 . There is a report of a very successful treatment of Weber-Christian's disease with cyclosporin A7.
The pathophysiology of the hemophagocytic syndrome is stiU unclear, although there is evidence that several cytokines (mainly IL2, PGE2, that some cases responded to therapy with cyclosporin A suggests a dysfunction of T lymphocytes and NK cells in the pathogenesis of macrophage activation 2 ,5,6,8. In the present case, the initial manifestation was pancytopenia and the only alterations we found were dyserythropoesis and the presence ofhemophagocytosis in bone marrow. There was no evidence of a family history. Initially, ITP was hypothesized but the use of corticosteroids did not result in an increase of platelets. Instead, the disease progressed with pancytopenia and an increase in hepatosplenomegaly and fever. Serological and molecular tests failed to demonstrate a bacterial or viral infection. Cell atypias were found in all three hemopoietic celllines, suggesting the diagnosis of myelodysplastic syndrome, but significant hemophagocytosis is not usually found in this condition ..Jmmunohistochemistry was used to exclude bone marrow involvement by lymphoma. This technique was also important in demonstrating the extent of the macrophage hyperplasia, and in confirming the diagnosis of the hemophagocytic syndrome.
The patient did not show any evidence of a rheumatologic disorder, neoplasia or a congenital disease. The clinicaI evolution was similar to that reported for "idiopathic" hemophagocytic syndrome 2 ,3, with bone marrow, liver, spleen and lymph node involvement by hemophagocytosis.
As it has been reported, there was no response to corticosteroids. Growth factors (G-CSF), as well as cytarabine in low doses were used with no response.
Reiner and Spivak 3 evaluated 23 patients and performed an extensive review of the literature about hemophagocytic histiocytosis. According to these authors, this syndrome may not be rare. In their experience, amo~g 2634 bone marrow cytological examinations, four cases with this syndrome were diagnosed per year (0,7%). The increase in viral infections and neoplasias, and the refinement of diagnostic techniques, are likely to enhance the diagnosis of hemophagocytic syndrome. As studies of the relationships between immunological mediators progress, a better understanding of the pathophysiologic mechanisms underlying this syndrome may be achieved.
RESUMO
A síndrome hemofagocítica (SH) caracteriza-se por <> um quadro clínico de febre, hepatoesplenomegalia, linfonodomegalia e pancitopenia periférica. A fagocitose de elementos hematopoiéticos por macrófagos, morfologicamente normais, está na origem da síndrome. A SH é considerada rara, manifestando~se como uma doença primária, ou associada a vírus, a neoplasias ou a doenças auto-imunes. O tratamento é controverso e a sua evolução, muitas vezes é fatal. A avaliação anátomo-patológica, apresenta o fenômeno da hemofagocitose em diversos órgãos, incluindo, principalmente, os hematopoéticos. Apresentamos os vários contextos clínicos no qual esta síndrome aparece, a importância do seu diagnóstico e o estudo da interação entre as citoquinas, as células imunorreguladoras e a terapêutica imunossupressora. Exemplificamos a síndrome hemofagocítica através de um caso clínico, com seus dados complementares, incluindo os necroscópicos.
